AU2020312840B2 — Pharmaceutical composition of imatinib
Assigned to Intas Pharmaceuticals Ltd · Expires 2026-01-22 · 0y expired
What this patent protects
The present invention relates to a pharmaceutical composition comprising imatinib or its pharmaceutically acceptable salt thereof and one or more pharmaceutical acceptable excipients in powder form, which can be reconstituted with a diluent just before administration. Further, th…
USPTO Abstract
The present invention relates to a pharmaceutical composition comprising imatinib or its pharmaceutically acceptable salt thereof and one or more pharmaceutical acceptable excipients in powder form, which can be reconstituted with a diluent just before administration. Further, the present invention provides process for the preparation of the said composition and its use for the treatment of cancer in pediatric patients.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.